38 results
S-3ASR
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary
424B5
AKRO
Akero Therapeutics Inc
6 Mar 24
Prospectus supplement for primary offering
5:16pm
, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine
424B5
AKRO
Akero Therapeutics Inc
4 Mar 24
Prospectus supplement for primary offering
5:21pm
of preferred stock may enable our board of directors to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest
424B5
6pynla2
17 May 23
Prospectus supplement for primary offering
4:45pm
424B5
0wiw57u7ysuuoc
15 Sep 22
Prospectus supplement for primary offering
5:16pm
424B5
jhvi8n9jrofr68 na9
13 Sep 22
Prospectus supplement for primary offering
5:11pm
424B5
skae 5zbeer8dcx19
16 Jun 22
Prospectus supplement for primary offering
6:52am
S-3ASR
h8ci6pdfa n1
18 May 21
Automatic shelf registration
6:01am